MXCT vs STX · rev $38.6M vs P/E 101, rev $12.20B
MaxCyte Inc (MXCT) versus Seagate Technology PLC (STX) — a side-by-side from cached financials, not a winner call.
MaxCyte Inc (MXCT) is a medical devices company listed on NASDAQ.
Seagate Technology PLC (STX) is a computer hardware company listed on NASDAQ.
Latest reported MXCT revenue for 2024-12-31 was $38.6M. Net income was -$41.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. MXCT currently screens at market cap $124.3M.
Latest reported STX revenue for 2026-07-03 was $12.20B. Net income was $3.18B. Revenue was up 34.1% from 2025-06-27 to 2026-07-03. STX currently screens at market cap $241.20B and trailing P/E 101.3.
MXCT currently screens at market cap $124.3M. STX currently screens at market cap $241.20B and trailing P/E 101.3.
Not investment advice. Open the MXCT and STX stock pages for the full models.
Not investment advice.